So, I appreciate the question. I can’t answer it with any more detail for obvious reasons, but I’m doing the best I can to address your question.
Reni Benjamin: Yeah, enough. Thanks. I appreciate that. Good luck going forward.
Daniel Passeri: Thank you.
Operator: [Operator Instructions] There are no further questions at this time. Daniel Passeri, please proceed with your closing remarks.
Daniel Passeri: Yeah, great. Thank you. First, we want to thank those of you listening in to this call and recognizing the importance of our mission towards developing these important novel therapeutics for enhancing patient treatment outcomes for debilitating disease. We want to thank our employees for their consummate dedication and professionalism helping us achieve our mission. And obviously, we want to thank our shareholders and Board of Directors for their support. Most importantly, we want to thank the patients and their families participating in these ongoing and important trials. So, thank you again for listening in and take care. Thank you.
Operator: Ladies and gentlemen, this concludes today’s conference call. Thank you for joining. You may now disconnect.
